Zhongnan Medical Journal Press

Home Results

A total of 17 result was found. Results that relate to Myocardial infarction

Treatment of gestational hypertension complicated with acute myocardial infarction: a case report and literature review

Published on New Medicine 2023,33(6):457-462.
14604 times 2938 times

Zhi-Li JIN Zi-Yue ZENG Wei XIONG Lin RONG Yu-Qiong CHAI Ming Chen Hai-Rong WANG Zhi-Bing LU

Acute myocardial infarction Gestational hypertension Coronary aneurysmal dilatation Thrombus
Details
Acute myocardial infarction mortality among Chinese residents from 2002 to 2021: an age-period-cohort model analysis

Published on Journal of Mathematical Medicine 2023,36(10):721-726.
17229 times 2971 times

Dan DONG Yan-Qiu SUN Yan YAN

Acute myocardial infarction Mortality Trend Age-period-cohort model
Details
Analysis of the influencing factors of MACE within 6 months after pPCI in acute STEMI patients and construction of risk prediction Nomogram model

Published on Journal of Mathematical Medicine 2024,37(2):108-118.
10439 times 3646 times

HAO Yuntao DING Lingling WAN Yanbo WANG Yong

Acute ST segment elevation myocardial infarction Primary percutaneous coronary intervention Major adverse cardiovascular events Influence factor Risk prediction model
Details
Hydrogel modulate macrophages to promote myocardial repair after myocardial infarction

Published on New Medicine 2024,34(5):572-581.
13468 times 2820 times

HUANG Huihui CAI Yongxiang DU Huan CHENG Panke LI Gang TAO Jianhong

Myocardial infarction Myocardial repair Hydrogels Macrophage
Details
Clinical study on effect of Qili Qiangxin capsules on the prognosis in patients with ST-segment elevation myocardial

Published on Chinese Journal of Pharmacoepidemiology 2024,33(6):612-620.
10678 times 2209 times

ZHU Hailong XIAO Weigang ZHANG Shaofei

Qili Qiangxin capsules ST elevation myocardial infarction Major adverse cardiovascular and cerebrovascular events Prognosis
Details
Construction of a risk prediction model for 1-year readmission in patients undergoing percutaneous coronary intervention treated with bayaspirin combined with clopidogrel

Published on Frontiers in Pharmaceutical Sciences 2024,28(1):41-48.
9985 times 1564 times

LYU Yuan CHEN Peipei WU Qiongbi ZHANG Wei

Myocardial infarction Percutaneous coronary intervention Readmission Predictive model Bayaspirin Clopidogrel
Details
Efficacy and safety of alirocumab after PCI in patients with acute myocardial infarction: a Meta-analysis

Published on Journal of Mathematical Medicine 2024,37(10):761-774.
12923 times 2446 times

BI Longfei LIU Yao YU Dan DAN Xuechuan LI Kui

Alirocumab Acute myocardial infarction Percutaneous coronary intervention Meta-analysis Randomized controlled trial
Details
Analysis of the clinical effect of intracoronary injection of recombinant human prourokinase on emergency percutaneous coronary intervention

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1209-1218.
12584 times 2287 times

ZHENG Heng GAN Shouyi FU Jing LI Bin

Acute ST segment elevation myocardial infarction Emergency PCI Recombinant human prourokinase Clinical effect
Details
Efficacy and safety of dapagliflozin combined with sacubitril valsartan in the treatment of heart failure after acute myocardial infarction: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1254-1264.
13495 times 2518 times

BI Longfei LIU Yao LIU Bingxia LI Kui

Dapgliflozin Sacubitril valsartan Myocardial infarction Heart failure Meta-analysis Systematic review Randomized controlled trial
Details
Influencing factors of dual antiplatelet therapy in conjunction with atorvastatin calcium tablets on recurrent myocardial infarction in patients following percutaneous coronary intervention

Published on Frontiers in Pharmaceutical Sciences 2025,29(1):106-113.
11173 times 1593 times

ZHOU Xiaokai FU Anyi JIN Qizhi

Aspirin Clopidogrel Myocardial infarction Percutaneous coronary intervention Recurrent myocardial infarction Influencing factors Losigtic regression
Details
Myocardial infarction induced by penpulimab and anlotinib: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):231-235.
11265 times 1806 times

WANG Chunhui JIANG Mengfei WU Wei ZHOU Yuhong

Immune checkpoint inhibitor Tyrosine kinase inhibitor Myocardial infarction Adverse drug reaction
Details
Management experience of ventricular septal defect complicating acute myocardial infarction: a case report of delayed presentation and literature review

Published on Journal of Mathematical Medicine 2025,38(7):551-557.
15002 times 1723 times

ZHANG Hanyu LU Zhibing

Acute myocardial infarction Ventricular septal defect Mechanical complications Case report
Details
The impact of predictive nursing intervention based on modified early warning score on the prognosis of patients with acute myocardial infarction: a Meta- analysis

Published on New Medicine 2025,35(11):1324-1332.
7140 times 1322 times

WANG Min XU Jingjing NIU Liqiao LIU Mei ZHENG Lina WANG Chaohui FENG Bingbing

Acute myocardial infarction Early warning score Predictive Nursing Meta-Analysis
Details
The clinical significance and application value of oxidative stress score in patients with acute myocardial infarction undergoing interventional therapy

Published on Journal of Mathematical Medicine 2025,38(12):910-922.
4466 times 892 times

TIAN Hua YANG Liang ZHANG Yong LIU Fang

Acute myocardial infarction Oxidative stress score Percutaneous coronary intervention Prognosis
Details
Role and mechanism of RGS14 in improving acute myocardial infarction by inhibiting TAK1 activation

Published on New Medicine 2026,36(2):169-178.
3917 times 1010 times

WU Qinghua DUAN Shaofeng TAN Chongyuan ZHANG Lirong ZHANG Jiaxing HU Yufeng SHE Zhigang LI Hongliang

Regulator of G-protein signaling 14 Acute myocardial infarction Inflammation Apoptosis TAK1
Details